Alice Goodman

Although the intra-cerebral hemorrhage (ICH) score at hospital admission is typically used to estimate the potential prognosis in stroke patients, a new study suggests that the 24-hour ICH score is a more accurate assessment.

According to a randomized, controlled clinical trial reported at the Emerging Science session, pregabalin was found effective in relieving chronic neuropathic pain and pain-related sleep disturbances associated with spinal cord injury.

Results from the FREEDOMS II trial found oral fingolimod administered at a daily dose of 0.5 mg to reduce relapse rates by almost 50% in patients with relapsing-remitting multiple sclerosis (RRMS).

The 2012 Annual Meeting of the American Academy of Neurology presented a phase 3 randomized, double-blind clinical trial which found that levodopa-carbidopa intestinal gel was more effective than standard oral levodopa-carbidopa.

Updated guidelines for prevention of chronic migraine headache were unveiled during the 2012 Annual Meeting of the American Academy of Neurology.

A new study presented at the 2012 Annual Meeting of the American Academy of Neurology suggests that the drug florbetaben can be used as a biomarker with positron emission tomography (PET) imaging to diagnose AD by detecting amyloid plaques in the brains of living people suspected of having AD.

Drug elevates lipid particles that are thought to be protective, leaves proatherogenic particles unchanged, and reduces markers of inflammation.

Osteoporosis guidelines and a Web-based tool allow physicians to identify patients for treatment and calculate 10-year fracture risk.

Study suggests that anti-tumor necrosis factor inhibitors may reduce the risk of developing Alzheimer's disease in patients with rheumatoid arthritis.

Bonus coverage of study results announced at ACR/ARHP 2010 showing the effects of statins on cardiovascular disease risk in children with lupus.

Researchers report disappointing study results showing that vitamin D supplementation has no effect on slowing the progression of knee osteoarthritis.

Advice for rheumatologists on selecting the right practice and key terms of employment to consider when negotiating a private practice contract.

Investigational drug achieves promising results in patients with rheumatoid arthritis who previously had an inadequate response to DMARD therapy.

Although mortality is not increased in patients with fibromyalgia, the risk of death from accidents and suicides is increased in these patients.

Ultrasound-guided steroid injections for knee osteoarthritis are less painful, provide more pain relief, and cost less than conventional palpation.

Revised evidence-based guidelines for non-pharmacologic treatments of osteoarthritis were unveiled at the 2010 Annual Meeting of the ACR.

Data from the 2010 ACR Annual Meeting suggest that new criteria that incorporate genetic risk factors can identify patients at high risk for RA.

Study results presented at the 2010 Annual Meeting of the ACR suggest that early treatment of even undifferentiated RA can improve outcomes.

A novel mitral valve clip was proven to be as safe and effective as open-chest surgery in selected patients with mitral valve regurgitation.

Genetic testing as part of initial management of patients on warfarin reduced hospitalizations by nearly 30%.

A novel drug-eluting stent using a new alloy and design achieved comparable outcomes versus earlier generation drug-eluting stents in the PERSEUS trial.

Remote monitoring of patients with an ICD had shorter times to clinical decision-making versus standard office visits in the CONNECT trial.

Portable ORs, using thoughts to control motions, and auto-anesthesia--these are some of the technologies that will transform the practice of cardiology.

A cryoablation catheter system was nearly 10 times more effective than standard drug therapy in eliminating intermittent atrial fibrillation and equally safe.

A customized vaccine using a patient’s own tumor cells called BiovaxID, prolonged disease-free survival in patients with follicular lymphoma who maintained complete remission after chemotherapy for one year and were then treated with the vaccine.

Alternating mammography and MRI every 6 months appears to be the best way to detect cancer in high-risk women, an M.D. Anderson study found. This strategy can identify cancers not found by mammography alone, said Huong Le-Petross, MD, assistant professor, Diagnostic Radiology, who presented a retrospective pilot study at a poster session during the San Antonio Breast Cancer Symposium.

Estimating survival for patients with early breast cancer for up to 15 years is possible, report researchers from Duke.

Herceptin plus docetaxel/cyclophosphamide (HER TC) adjuvant therapy—a non-anthracycline-containing regimen—was tolerable with acceptable safety for lower risk patients with HER2-positive early breast cancer, according to a large Phase II study.

Although hormonal therapy with aromatase inhibitors is highly effective at preventing recurrence in menopausal women with breast cancer, several studies have shown that adherence leaves something to be desired.